drugset / Trial / NCT00332917
An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD Patients
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is a multicenter, 6 months open label safety extension study for all patients who are willing and eligible to continue from the pivotal, double-blind S308.3.001 trial
Timeline
- Start
- 2007-02
- Primary completion
- 2008-07
- Completion
- 2008-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pardoprunox | Small molecule | — | — |